Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.
David Luedeker
Advertisement
David Luedeker is the principal scientist, solid formulation, for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.
Articles by David Luedeker
Advertisement
Latest Updated Articles
- Seven Trends Shaping the Future of Pharmaceutical Formulation Development
Published: October 7th 2022 | Updated:
Advertisement
Advertisement
